Shares of Tenet Healthcare Co. (NYSE:THC) have earned an average rating of “Buy” from the eighteen research firms that are presently covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $84.71.
A number of research analysts have recently commented on THC shares. Truist Securities upped their price objective on shares of Tenet Healthcare from $78.00 to $90.00 and gave the company a “hold” rating in a research note on Wednesday, January 5th. Citigroup upped their price objective on shares of Tenet Healthcare from $88.00 to $91.00 and gave the company a “buy” rating in a research note on Monday, October 25th. Barclays increased their target price on shares of Tenet Healthcare from $81.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 21st. Stephens increased their target price on shares of Tenet Healthcare from $77.00 to $92.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 9th. Finally, SVB Leerink increased their target price on shares of Tenet Healthcare from $78.00 to $88.00 and gave the stock a “market perform” rating in a research report on Friday, January 7th.
In other news, Chairman Ronald A. Rittenmeyer sold 29,974 shares of the stock in a transaction that occurred on Monday, November 15th. The stock was sold at an average price of $80.38, for a total transaction of $2,409,310.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Audrey T. Andrews sold 56,626 shares of the stock in a transaction that occurred on Friday, November 12th. The shares were sold at an average price of $78.46, for a total value of $4,442,875.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 139,564 shares of company stock valued at $10,978,279. Company insiders own 1.60% of the company’s stock.
NYSE:THC opened at $81.04 on Friday. The firm has a market cap of $8.68 billion, a price-to-earnings ratio of 8.11, a price-to-earnings-growth ratio of 8.16 and a beta of 2.56. The company has a current ratio of 1.28, a quick ratio of 1.21 and a debt-to-equity ratio of 8.57. The company’s 50-day moving average is $77.30 and its two-hundred day moving average is $72.49. Tenet Healthcare has a 12-month low of $45.04 and a 12-month high of $83.69.
Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Tuesday, October 19th. The company reported $1.99 EPS for the quarter, beating the Zacks’ consensus estimate of $1.09 by $0.90. Tenet Healthcare had a net margin of 5.52% and a return on equity of 58.52%. The company had revenue of $4.89 billion during the quarter, compared to the consensus estimate of $4.84 billion. During the same quarter in the prior year, the company posted $0.64 EPS. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. On average, equities research analysts forecast that Tenet Healthcare will post 6.46 earnings per share for the current fiscal year.
About Tenet Healthcare
Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices.
See Also: Dividend Aristocrat Index
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.